The Europe Stretch Marks Treatment Market was valued at USD 0.72 billion in 2024. The Europe Stretch Marks Treatment Market is expected to have 6.77 % CAGR from 2025 to 2033 and be worth USD 1.30 billion by 2033 from USD 0.77 billion in 2025.
The growing number of people suffering from stretch marks in European countries is driving the European market. The growing population of overweight and increasing adoption of technological advancements in treatment procedures such as laser treatment and microdermabrasion are anticipated to contribute to the growth of the European stretch marks treatment market. In addition, the rising demand for aesthetic treatment and increasing awareness of aesthetic treatments, particularly among pregnant women, stimulate market growth. In addition, habits such as smoking and alcohol consumption in people who have reportedly declined are increasing, in less educated people, supporting the growth rate of the regional market. Moreover, increasing preference from consumers for these procedures is accelerating the growth of the Europe stretch marks treatment market.
In addition, intense competition between the key market participants provides profitable opportunities to introduce more innovative techniques to amplify the growth of the European market. Furthermore, these products cost less when compared, making them more affordable to low and middle-income people in the region's countries. 1.9 billion adults are overweight, of which 650 million are obese, propelling the European market growth.
However, the treatment concerned with stretch marks is so expensive in this region, impeding the regional market growth. Also, side effects associated with skin when laser treatment takes place obstruct the regional market growth. Strict regulations overriding the operations may be inhibiting the increase in the market of the region.
Based on treatment, the laser therapy segment is anticipated to hold the major share of the Europe stretch marks treatment market during the forecast period.
Based on end-user, the home-use is expected to occupy the most significant share of the Europe stretch marks treatment market during the forecast period.
The European stretch marks treatment market is assumed as a developed market and is anticipated to witness significant growth during the forecast period. The European stretch marks treatment market had the second-largest global market share in 2024 and fell right behind North America in showcasing dominance. Factors such as the growing investments and support from the European governments and increasing research and developmental activities by the key market participants are propelling the European market growth.
The UK stretch marks treatment market had the major share of the European stretch marks treatment market in 2024 and is expected to register a promising CAGR during the forecast period owing to increasing discretionary expenses in urban areas, growing obesity on increasing consumption of fatty foods; sedentary lifestyles are enormous reasons for stretch marks in the UK. The gIn addition, the growing perception of pregnant women who are excessively prone to stretch marks is fueling the growth in the UK market.
The German stretch marks treatment market accounted for a substantial share of the European market in 2024 and is anticipated to showcase a notable CAGR during the forecast period. The growth of the German market is primarily driven by the growing urbanization and increasing promotional and advertisements by the key market participants to increase awareness among people regarding the launched products and their effectiveness in treating stretch marks. A quick surge in traditional in young humans undergoing adolescence stimulates the market. Developed product upgrading and ascending focus on plastic surgeries and lifestyle changes in the region are flourishing. The growth in demand for increasing the production rate of medicinal products is fuelling the market.
Companies such as Syneron Medical Ltd., E.T. Browne Drug Co., Inc., Union-Swiss (Pty) Ltd., Basq Skincare, Ellipse A/S, Laboratoires Expanscience, Clarins Group, Merz North America, Inc., Cynosure, Inc., The Boppy Company LLC, Helix BioMedix, Inc., Weleda AG, Dermaclara, Inc., Mama Mio US, Inc., and Centre Light Solutions, LLC are anticipated to play a noteworthy role in the European stretch marks treatment market.
By End User
By Country
Frequently Asked Questions
The Europe stretch marks treatment market size is expected to be worth USD 1.30 million by 2033.
Countries such as the UK and Germany have higher chances to register the lead in the European market during the forecast period.
Syneron Medical Ltd., E.T. Browne Drug Co., Inc., Union-Swiss (Pty) Ltd., Basq Skincare, Ellipse A/S, Laboratoires Expanscience, Clarins Group, Merz North America, Inc., Cynosure, Inc., The Boppy Company LLC, Helix BioMedix, Inc., Weleda AG, Dermaclara, Inc., Mama Mio US, Inc., and Centre Light Solutions, LLC. are some of the notable companies in the European stretch marks treatment market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region